Progress in research of liver surgery in China
- PMID: 11819694
- PMCID: PMC4728261
- DOI: 10.3748/wjg.v6.i6.773
Progress in research of liver surgery in China
Similar articles
-
Liver surgery and transplantation in China: Progress and Challenges.Front Med China. 2007 Feb;1(1):1-5. doi: 10.1007/s11684-007-0001-y. Epub 2007 Feb 1. Front Med China. 2007. PMID: 24557608
-
The past, present, and future of liver cancer research in China.Cancer Lett. 2023 Oct 10;574:216334. doi: 10.1016/j.canlet.2023.216334. Epub 2023 Aug 11. Cancer Lett. 2023. PMID: 37574184
-
[Research progress of immunotherapy alone and in combination for liver cancer].Zhonghua Gan Zang Bing Za Zhi. 2020 Jun 20;28(6):471-474. doi: 10.3760/cma.j.cn501113-20200520-00262. Zhonghua Gan Zang Bing Za Zhi. 2020. PMID: 32660173 Chinese.
-
[Research progress of liver disease treatment by Zhuang medicines].Zhongguo Zhong Yao Za Zhi. 2018 Jun;43(11):2224-2229. doi: 10.19540/j.cnki.cjcmm.20180327.001. Zhongguo Zhong Yao Za Zhi. 2018. PMID: 29945371 Review. Chinese.
-
[Progress in immunotherapy for hepatocellular carcinoma].Sheng Wu Gong Cheng Xue Bao. 2019 Dec 25;35(12):2326-2338. doi: 10.13345/j.cjb.190339. Sheng Wu Gong Cheng Xue Bao. 2019. PMID: 31880139 Review. Chinese.
Cited by
-
Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases.J Cancer Res Clin Oncol. 2009 Aug;135(8):1067-72. doi: 10.1007/s00432-009-0546-z. Epub 2009 Mar 18. J Cancer Res Clin Oncol. 2009. PMID: 19294419 Free PMC article.
-
Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma.J Clin Pathol. 2005 May;58(5):500-3. doi: 10.1136/jcp.2004.023556. J Clin Pathol. 2005. PMID: 15858121 Free PMC article.
-
Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.World J Gastroenterol. 2002 Aug;8(4):658-62. doi: 10.3748/wjg.v8.i4.658. World J Gastroenterol. 2002. PMID: 12174374 Free PMC article.
-
Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma.World J Gastroenterol. 2007 Jan 21;13(3):414-20. doi: 10.3748/wjg.v13.i3.414. World J Gastroenterol. 2007. PMID: 17230611 Free PMC article.
-
Experimental study on the feasibility and safety of radiofrequency ablation for secondary splenomagely and hypersplenism.World J Gastroenterol. 2003 Apr;9(4):813-7. doi: 10.3748/wjg.v9.i4.813. World J Gastroenterol. 2003. PMID: 12679939 Free PMC article.
References
-
- Tang ZY. Advances in clinical research of hepatocellular carcinoma in China. Huaren Xiaohua Zazhi. 1998;6:1013–1016.
-
- Liver disease study group of second military medical college. Intrahepatic anatomy of normal people in China. Zhonghua Waike Zazhi. 1962;2:97–103.
-
- Yang CH, Liu YX, Feng YQ. Double embolization for the treatment of advanced liver cancer via hepatic artery and portal vein. Zhonghua Waike Zazhi. 1996;34:575.
-
- Tang ZY, Liu KD, Fan Z, Lu JZ, Zhang YJ, Hou Z, Bao YM, Zhou D, Tang WY, Xia XL, et al. Targeting therapy of hepatocellular carcinoma: experimental and clinical studies. Zhongliu. 1990;10:241–245.
-
- Tu ZX, Wu MC, Cui ZF. [The early detection of hepatocellular cancer by using alpha-feto-protein microheterogeneity] Zhonghua Nei Ke Za Zhi. 1986;25:272–25, 272-25. - PubMed
LinkOut - more resources
Full Text Sources